CHICAGO, Oct. 27, 2014 /PRNewswire/ -- Rottendorf Pharmaceuticals today reported that it has doubled its annual revenues in the three years since its establishment as the U.S. subsidiary of Rottendorf Pharma GmbH, which has developed formulations and manufactured and packaged solid oral dosage forms for pharmaceutical clients for 85 years. Rottendorf Pharma is a top 20 contract manufacturing organization (CMO) producing 600 products annually for more than 200 clients worldwide. The increase in sales generated by Rottendorf Pharmaceuticals since its 2011 launch has more than doubled the percentage of corporate revenues coming from clients in the U.S.
Gordon Haines, CEO of Rottendorf Pharmaceuticals, commented, "Our robust revenue growth reflects the distinctive strengths that have made our parent company a significant force in the CMO sector for many decades. We celebrated our third anniversary by signing on a top five pharma customer, and we are proud of the fact that our new business primarily comes from word-of-mouth referrals, a reflection of the exceptional quality, deep expertise, proactive problem-solving and strong customer focus that have driven our business from our earliest days."
Mr. Haines continued, "Our mantra that our customers come first is exemplified by our commitment to Total Process Ownership, where we assume primary responsibility for the success of client projects from start to finish. We also are fortunate to have a unique corporate structure, with ownership held by a charitable foundation that allows us to focus on the long term success of our customers and our business, rather than on short-term results."
Rottendorf develops formulations and manufactures solid oral dosage forms in GMP facilities that are inspected by FDA, EMEA, ANVISA, and others, handling batches from 2 to 750 kilograms. Rottendorf's large staff of over 40 formulation scientists and highly experienced technical experts provide cost-effective, efficient product transfer and manufacturing processes and proactive problem-solving that result in deviation-free manufacturing and on-time delivery. Rottendorf also offers a wide variety of flexible and cost-effective packaging options under GMP conditions.
To learn more about Rottendorf Pharmaceuticals' distinctive capabilities in the formulation, production and packaging of solid dosage forms, visit Booth 517 at the 2014 Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists (AAPS) to be held November 2- 6, 2014 in San Diego, CA. For more information about the 2014 AAPS meeting, visit www.aaps.org/annualmeeting.
About Rottendorf Pharmaceuticals Rottendorf Pharmaceuticals is the U.S. subsidiary of Rottendorf Pharma GmbH, a German company that has manufactured pharmaceutical products for 85 years, with expertise in the formulation, manufacture and packaging of solid oral dosage forms for pharmaceutical clients worldwide. Rottendorf's broad-ranging expertise, global regulatory capabilities, commitment to quality and exceptional customer service have made it one of the top 20 CMO's in the world. For more information, visit http://www.rottendorfus.com.
Contacts: Media
Rottendorf Pharmaceuticals Barbara Lindheim
Gordon Haines Brandwidth Solutions CEO (212) 584-2276
(312) 794-7836 blindheim@brandwidthsolutions.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/contract-manufacturer-rottendorf-marks-third-anniversary-of-fast-growing-us-subsidiary-that-has-increased-revenues-four-fold-787468742.html
SOURCE Rottendorf Pharmaceuticals
